SGMS2 and central nervous system cancer: In addition, we reported that the pharmacological effect of 2OHOA is due to the increase of SMS1 expression and enzymatic activity, and simultaneous reduction of SMS2 in glioma cells, which regulate cell growth and patient prognostic.